Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
about
Current Research Therapeutic Strategies for Alzheimer's Disease TreatmentAmylin at the interface between metabolic and neurodegenerative disordersOn the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP PeptidesUnraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives.Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease.Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.Amylin-mediated control of glycemia, energy balance, and cognition.Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease.Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.Editorial on, "Amyloid-beta clearance in Alzheimer's disease".Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.Amylin in Alzheimer's disease: Pathological peptide or potential treatment?Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.A Hot-Segment-Based Approach for the Design of Cross-Amyloid Interaction Surface Mimics as Inhibitors of Amyloid Self-Assembly.
P2860
Q26765530-C1A3E801-429E-45A2-A28E-6840DFE01C95Q27003342-620795C5-25DD-4701-8D7A-E5042DF798CFQ27022467-E0EB38F3-87C8-4D73-948A-674BECE3012CQ33362745-F8AE3CAC-DC7D-4620-B27A-6A0B9BAF597CQ33800802-8C06A5AF-3832-4182-8694-51036BED06CFQ37297656-49B05E05-67F0-4D84-8610-F9340951702AQ38601445-BC3223F6-8E89-4199-87D8-F989A10225B7Q38753342-8F05E2CA-C1DC-4AA8-8433-C831464FD6E0Q39136356-743D0AF7-8CA8-4EA8-812C-EC3BDE308A6FQ39320824-7E2742C9-E183-4C96-B919-7AFED0D9A135Q39401091-283C1313-F714-4321-B652-5C9D0DE53B22Q43015317-6E148C42-8D77-4B53-9917-AF893030B0F9Q47095823-E22C3011-F4E9-4DEB-8C10-E438B9D84D05Q47322028-5CFF025F-3D5A-4A0A-929B-86A5374EE3D6Q51246561-F9D94DA1-A24F-4F75-81AF-CE895869E138Q52919726-29C3E316-4CF8-4222-9638-4F384D7B3B61
P2860
Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
@en
type
label
Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
@en
prefLabel
Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
@en
P2860
P356
P1476
Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
@en
P2093
Haihao Zhu
Wei Qiao Qiu
P2860
P356
10.3389/FNAGI.2014.00186
P577
2014-07-29T00:00:00Z